CANCER: Mortality rate spike seen in smokers on HRT comboEight-year study finds 61% greater likelihood of death from NSCLC CANCER: Erlotinib-bevacizumab combo beats bevacizumab alone CANCER: Second-line chemotherapy patients benefit from vandetanib Drop of 21% in risk of disease progression seen after 13-month followup CANCER: Pemetrexed boosts non-small cell survival rates Patients with nonsquamous cell carcinoma live up to 5.2 months longer, research shows Income gap in Ontario cancer screening Low rate of follow-up care to abnormal Pap tests Breast cancer testing to restart Annual screening for skin cancer: Reasons for non-compliance Ovary removal linked to higher risk of lung cancer Canadian researcher says result is preliminary, but intriguing Ovarian Cancer Helping patients navigate treatment courses and manage side effects CANCER: New gene assay predicts colon cancer recurrence First Previous 71 72 73 74 75 Next Last
